Clinical Trial Update: Influence of Enteral Microbiome on Mortality of Patients With Cardiogenic Shock

View source ↗

Summary

A completed clinical trial evaluating whether enteral microbiome modulation affects mortality in patients with cardiogenic shock.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Heart Failure
• Myocardial Infarction
• Out-of-hospital Cardiac Arrest

Snippet

Sponsor: University Hospital, Essen | Conditions: Cardiogenic Shock, Microbial Colonization | Status: COMPLETED